Literature DB >> 30958976

Update in Chronic Obstructive Pulmonary Disease 2018.

Wassim W Labaki1, Lucas M Kimmig2, Gökhan M Mutlu2, MeiLan K Han1, Surya P Bhatt3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30958976      PMCID： PMC6835078          DOI： 10.1164/rccm.201902-0374UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  110 in total

1.  Endobronchial Lung Volume Reduction in Severe Emphysema. Time to Translate Randomized Controlled Trial Results into Routine Clinical Practice?

Authors:  Gaetan Deslee
Journal:  Am J Respir Crit Care Med       Date:  2018-11-01       Impact factor: 21.405

2.  To Withdraw or Not to Withdraw Inhaled Corticosteroids from Triple Therapy in Chronic Obstructive Pulmonary Disease.

Authors:  Donald P Tashkin
Journal:  Am J Respir Crit Care Med       Date:  2018-08-01       Impact factor: 21.405

3.  Generic Respiratory Symptoms and Branded Lung Diseases. Same Difference?

Authors:  Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

4.  Long-Term Oxygen Therapy: The Three Big Questions.

Authors:  Richard Casaburi
Journal:  Ann Am Thorac Soc       Date:  2018-01

5.  The "Obesity Paradox" in Chronic Obstructive Pulmonary Disease: Can It Be Resolved?

Authors:  Anand S Iyer; Mark T Dransfield
Journal:  Ann Am Thorac Soc       Date:  2018-02

6.  Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.

Authors:  Ken M Kunisaki; Mark T Dransfield; Julie A Anderson; Robert D Brook; Peter M A Calverley; Bartolome R Celli; Courtney Crim; Benjamin F Hartley; Fernando J Martinez; David E Newby; Alexa A Pragman; Jørgen Vestbo; Julie C Yates; Dennis E Niewoehner
Journal:  Am J Respir Crit Care Med       Date:  2018-07-01       Impact factor: 21.405

7.  MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling.

Authors:  Melina M Musri; Núria Coll-Bonfill; Bradley A Maron; Víctor I Peinado; Rui-Sheng Wang; Jordi Altirriba; Isabel Blanco; William M Oldham; Olga Tura-Ceide; Jessica García-Lucio; Benjamin de la Cruz-Thea; Gunter Meister; Joseph Loscalzo; Joan A Barberà
Journal:  Am J Respir Cell Mol Biol       Date:  2018-10       Impact factor: 6.914

8.  Role of Comorbidities in Treatment and Outcomes after Chronic Obstructive Pulmonary Disease Exacerbations.

Authors:  Laura J Spece; Eric M Epler; Lucas M Donovan; Matthew F Griffith; Margaret P Collins; Laura C Feemster; David H Au
Journal:  Ann Am Thorac Soc       Date:  2018-09

9.  Gene Promoter Hypermethylation Detected in Sputum Predicts FEV1 Decline and All-Cause Mortality in Smokers.

Authors:  Shuguang Leng; Brenda Diergaarde; Maria A Picchi; David O Wilson; Frank D Gilliland; Jian-Min Yuan; Jill M Siegfried; Steven A Belinsky
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 30.528

10.  Risk Trajectories of Readmission and Death in the First Year after Hospitalization for Chronic Obstructive Pulmonary Disease.

Authors:  Peter K Lindenauer; Kumar Dharmarajan; Li Qin; Zhenqiu Lin; Andrea S Gershon; Harlan M Krumholz
Journal:  Am J Respir Crit Care Med       Date:  2018-04-15       Impact factor: 30.528
View more
  2 in total

1.  Decreased expression of PPARγ is associated with aortic endothelial cell apoptosis in intermittently hypoxic rats.

Authors:  Ningfang Lian; Mengxue Chen; Shuyi Zhang; Lida Chen; Jiefeng Huang; Qichang Lin
Journal:  Sleep Breath       Date:  2021-03-10       Impact factor: 2.816

2.  N-Acetylcysteine Improves Inflammatory Response in COPD Patients by Regulating Th17/Treg Balance through Hypoxia Inducible Factor-1α Pathway.

Authors:  Xiaopeng Liu; Zhixiong Hu; Haiying Zhou
Journal:  Biomed Res Int       Date:  2021-06-29       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.